Opioid Labeling Changes Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
5. Polygenetic Test Predicts Early Heart Disease Risk
An investigational test demonstrated superiority in detecting familial hypercholesterolemia compared with traditional methods.
4. Diabetes Drug Reverses Alzheimer's Disease in Mice
Mice treated with a repurposed diabetes medication performed better on learning and memory tests.
3. Plastic Surgery May Hold the Key to Reducing Migraine Pain
Migraine pain may be caused by nerves trapped between muscles, bones, and fascia, which could be reduced by forehead restoration surgery.
2. Medicaid Expansion Increased Access to Prenatal Care
Expanded Medicaid reduced the number of uninsured pregnant mothers by 8%.
1. FDA Revises Opioid Labeling to Restrict Pediatric Use
Cough and cold medicines containing codeine and hydrocodone are no longer indicated for use in pediatric patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025